Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry

Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry

Christina Gade Jespersen,1,2 Michael Borre,1 Mette N&oslash;rgaard21Department of Urology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, DenmarkPurpose: Large-scale observational studies...

Full description

Bibliographic Details
Main Authors:	Jespersen CG, Borre M, N&oslash;rgaard M
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-06-01
Series:	Clinical Epidemiology
Online Access:	http://www.dovepress.com/validity-of-the-recorded-codes-of-gonadotropin-releasing-hormone-agoni-a10143

Similar Items

Data quality in the Danish National Acute Leukemia Registry: a hematological data resource
by: &Oslash;stg&aring;rd LSG, et al.
Published: (2013-09-01)

Gonadotropin releasing hormone agonists: Expanding vistas
by: Navneet Magon
Published: (2011-01-01)

Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish National Patient Registry: a short report
by: Blichert-Hansen L, et al.
Published: (2013-01-01)

Luteinizing hormone-releasing hormone agonists versus orchiectomy in the treatment of prostate cancer: A systematic review
by: Xianlu Zhang, et al.
Published: (2023-02-01)

Validity of a procedure to identify patients with chronic idiopathic thrombocytopenic purpura in the Danish National Registry of Patients
by: Katrine Edith Klith Heden, et al.
Published: (2009-02-01)

Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
by: Kuo Yong-fang, et al.
Published: (2008-07-01)

Linkage between the Danish National Health Service Prescription Database, the Danish Fetal Medicine Database, and other Danish registries as a tool for the study of drug safety in pregnancy
by: Pedersen LH, et al.
Published: (2016-05-01)

Comorbidity and survival of Danish prostate cancer patients from 2000–2011: a population-based cohort study
by: Nguyen-Nielsen M, et al.
Published: (2013-11-01)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
by: Juan Carlos Castillo, et al.
Published: (2020-04-01)

A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
by: Feng Zhou, et al.
Published: (2016-01-01)

Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy
by: Azar Danesh, et al.
Published: (2007-08-01)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Eun Jin Han, et al.
Published: (2013-09-01)

Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
by: Choi S, et al.
Published: (2011-12-01)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
by: Binarwan Halim, et al.
Published: (2022-03-01)

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
by: Shinyoung Jang, et al.
Published: (2023-02-01)

USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
by: Yu. E. Dobrokhotova, et al.
Published: (2016-09-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Electrocardiogram Changes Following the Treatment with Gonadotropin-Releasing Hormone Agonists in Patients with Precocious Puberty
by: Ali Bagherzadeh, et al.
Published: (2021-11-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero
by: SERGIO E RECABARREN, et al.
Published: (2005-01-01)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
by: Jong Wan Yoon, et al.
Published: (2017-12-01)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
by: Hye Ryun Kim, et al.
Published: (2017-12-01)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
by: Yeon Hee Hong, et al.
Published: (2022-01-01)

Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is high
by: Lund JL, et al.
Published: (2013-08-01)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014-12-01)

Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty
by: Tao Chen, et al.
Published: (2020-01-01)

Positive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of Patients
by: Mette S&oslash;gaard, et al.
Published: (2011-02-01)

Comorbidity and survival of Danish lung cancer patients from 2000–2011: a population-based cohort study
by: Deleuran T, et al.
Published: (2013-11-01)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
by: Chen Q, et al.
Published: (2019-05-01)

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas
by: Peng-Hui Wang, et al.
Published: (2009-06-01)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
by: Dattaprasad B Inamdar, et al.
Published: (2012-01-01)

Effect of vaginal estriol use in total laparoscopic hysterectomy with gonadotropin-releasing hormone agonist therapy
by: Go Hirata, et al.
Published: (2018-01-01)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
by: Loukia Sifaki, et al.
Published: (2019-03-01)

Positive predictive values of the International Classification of Disease, 10th edition diagnoses codes for diverticular disease in the Danish National Registry of Patients
by: Rune Erichsen, et al.
Published: (2010-10-01)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
by: Wignall Jacqui, et al.
Published: (2010-04-01)

Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients
by: Bella Martazanova, et al.
Published: (2022-08-01)

Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols
by: Neena Malhotra, et al.
Published: (2013-01-01)

The impact of gonadotropin-releasing hormone agonist and hormone replacement therapy in placement of hormone replacement therapy on outcomes of IVF after hysteroscopic polypectomy
by: Yiu-Tai Li, et al.
Published: (2024-03-01)

Transcriptome profiling reveals superovulation with the gonadotropin-releasing hormone agonist trigger impaired embryo implantation in mice
by: Meng Li, et al.
Published: (2024-02-01)